| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.45▲ | 10.45▲ | 10.45▲ | 10.50▼ | 10.49▲ |
| MA10 | 10.43▲ | 10.43▲ | 10.43▲ | 10.50▲ | 10.46▲ |
| MA20 | 10.42▲ | 10.43▲ | 10.43▲ | 10.48▲ | 10.44▲ |
| MA50 | 10.35▲ | 10.30▲ | 10.26▲ | 10.45▲ | 10.24▲ |
| MA100 | 10.19▲ | N/A | N/A | 10.42▲ | N/A |
| MA200 | N/A | N/A | N/A | 10.27▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.001▼ | -0.003▼ | 0.001▲ | -0.005▼ |
| RSI | 78.829▲ | 77.686▲ | 81.648▲ | 61.318▲ | 73.451▲ |
| STOCH | 78.060 | 78.060 | 79.449 | 31.190 | 67.648 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -71.429 | -47.619 |
| CCI | 226.384▲ | 227.416▲ | 232.927▲ | 61.918 | 154.208▲ |
|
Thursday, September 18, 2025 06:59 AM
Minovia Therapeutics Ltd. (“Minovia” or the “Company”), a clinical-stage biotechnology company developing novel therapies to treat mitochondrial diseases and combat age-related decline, announces that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 10.53 | 10.53 | 10.50 | 10.50 | 2,227 |
| 29/09/25 | 10.52 | 10.60 | 10.50 | 10.51 | 6,000 |
| 26/09/25 | 10.50 | 10.50 | 10.50 | 10.50 | 4,200 |
| 25/09/25 | 10.50 | 10.50 | 10.50 | 10.50 | 6,100 |
| 24/09/25 | 10.51 | 10.512 | 10.50 | 10.512 | 6,800 |
| 23/09/25 | 10.50 | 10.50 | 10.49 | 10.50 | 29,900 |
| 22/09/25 | 10.50 | 10.50 | 10.49 | 10.49 | 3,500 |
| 19/09/25 | 10.60 | 10.60 | 10.48 | 10.50 | 5,600 |
| 18/09/25 | 10.48 | 10.50 | 10.46 | 10.50 | 24,400 |
| 17/09/25 | 10.48 | 10.48 | 10.48 | 10.48 | 11,500 |
|
|
||||
|
|
||||
|
|